During a live event, Thomas G. Martin, MD, discussed updated findings from the CARTITUDE-1 trial of cilta-cel and what they signify for patients with no disease progression at 5 years.
Abstract: The continual growth of the computer vision and artificial intelligence fields overtime have provided the basis for more efficient and accurate surveillance. This paper examines the use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback